Inspired by the idea of applying computation and statistics towards complex biology in the ‘omics’ era, I obtained diverse training as a data scientist dedicated to advancing human health. With a decade of experience spanning across academia and biotech roles, I'm excited to join the Entact Bio team to develop a new drug discovery platform for bringing new drugs to patients.
Outside of work, I treasure spending time with my loved ones and training for marathons.
Want to work with Ryan?
See our latest job openingsGuiding a young, groundbreaking company to maturity calls for a leader who can strike the right balance between oversight and support. Victoria Richon is hoping to provide just that as the new CEO of Entact Bio, a preclinical biotech that came out of stealth in December...
The language of drug development is often militaristic. Medicinal chemists build arsenals of small molecules—looking for inhibitors or “warheads” that can hit “targets” and “combat” disease. Block, eliminate, disrupt, halt. For decades, drug makers have sought “magic bullets” that can precisely destroy ...
When proteins within the body get tagged with a molecule called ubiquitin, they are essentially marked for destruction. But they can be saved; a deubiquitinase enzyme can remove the ubiquitin, keeping the protein intact. That, at least in part, is what Entact Bio aims to do...
A small startup in Watertown has raised millions of dollars for early-stage research on a potentially powerful new idea that’s beginning to take hold in the biotech industry: designing drugs to enhance or prolong the function of helpful proteins that ward off disease. If successful, the approach could lead to new therapie...
Copyright © 2023
